NSAIDs | COX-2 | |
Efficacy for moderate to severe acute pain (numbers needed to treat—NNT) | Diclofenac 50mg (2.3) Ibuprofen 400mg (2.4) Ketorolac 10mg (2.6) | Celecoxib 200mg (4.5) Parecoxib 20mg (3.0) Valdecoxib 20mg (1.7) |
Renal function | Can affect renal function postoperatively | Similar adverse effects on renal function |
Gastrointestinal | Acute gastroduodenal damage and bleeding can occur. Risk increased with higher doses, history of GI ulceration, long-term use, and elderly | Less clinically significant peptic ulceration than NSAIDs (VIGOR and CLASS studies) |
Platelet function | Inhibit platelet function but do not significantly increase surgical blood loss in normal patients. Associated with higher incidence of post-tonsillectomy haemorrhage | Do not impair platelet function |
Aspirin-exacerbated respiratory disease | 10–15% of asthmatics affected when given aspirin. Cross-sensitivity with NSAIDs | Do not produce bronchospasm |
Bone healing | Impaired in animal models. No good evidence that clinically important | Similar to NSAIDs |
NSAIDs | COX-2 | |
Efficacy for moderate to severe acute pain (numbers needed to treat—NNT) | Diclofenac 50mg (2.3) Ibuprofen 400mg (2.4) Ketorolac 10mg (2.6) | Celecoxib 200mg (4.5) Parecoxib 20mg (3.0) Valdecoxib 20mg (1.7) |
Renal function | Can affect renal function postoperatively | Similar adverse effects on renal function |
Gastrointestinal | Acute gastroduodenal damage and bleeding can occur. Risk increased with higher doses, history of GI ulceration, long-term use, and elderly | Less clinically significant peptic ulceration than NSAIDs (VIGOR and CLASS studies) |
Platelet function | Inhibit platelet function but do not significantly increase surgical blood loss in normal patients. Associated with higher incidence of post-tonsillectomy haemorrhage | Do not impair platelet function |
Aspirin-exacerbated respiratory disease | 10–15% of asthmatics affected when given aspirin. Cross-sensitivity with NSAIDs | Do not produce bronchospasm |
Bone healing | Impaired in animal models. No good evidence that clinically important | Similar to NSAIDs |
This PDF is available to Subscribers Only
View Article Abstract & Purchase OptionsFor full access to this pdf, sign in to an existing account, or purchase an annual subscription.